Molecular Templates Inc (MTEM)

Molecular Templates (MTEM) Income Statement


Molecular Templates Income Statement

Last quarter (Q3 2022), Molecular Templates's total revenue was $4.24M, an increase of 78.23% from the same quarter last year. In Q3, Molecular Templates's net income was $-24.64M. See Molecular Templates’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 21Dec 20Dec 19Dec 18Dec 17
Total Revenue
$ 35.11M$ 38.70M$ 15.63M$ 22.27M$ 13.29M$ 3.40M
Cost of Revenue
Gross Profit
Operating Expense
$ 112.22M$ 118.77M$ 116.48M$ 70.60M$ 44.28M$ 21.24M
Operating Income
$ -77.11M$ -80.07M$ -100.84M$ -48.33M$ -31.00M$ -17.85M
Net Non Operating Interest Income Expense
$ -3.77M$ -2.94M$ -677.00K$ 1.02M$ -239.00K$ -802.00K
Other Income Expense
--$ -3.39M$ -22.12M$ 951.00K$ -4.49M
Pretax Income
$ -80.89M$ -83.01M$ -104.91M$ -69.42M$ -30.29M$ -23.14M
Tax Provision
$ 26.00K$ 0.00$ 5.00K$ 0.00--
Earnings From Equity Interest Net Of Tax
Net Income Common Stockholders
$ -80.91M$ -83.01M$ -104.92M$ -69.42M$ -30.29M$ -24.10M
Basic EPS
$ -1.43$ -1.50$ -2.20$ -1.86$ -1.02$ -2.11
Diluted EPS
$ -1.43$ -1.50$ -2.20$ -1.86$ -1.02$ -2.11
Basic Average Shares
$ 225.30M$ 55.30M$ 47.60M$ 37.77M$ 29.60M$ 11.40M
Diluted Average Shares
$ 225.30M$ 55.30M$ 47.60M$ 37.77M$ 29.60M$ 11.40M
Dividend Per Share
Total Operating Income As Reported
Reported Normalized Basic E P S
Reported Normalized Diluted E P S
Rent Expense Supplemental
Total Expenses
$ 112.22M$ 118.77M$ 116.48M$ 70.60M$ 44.28M$ 21.24M
Net Income From Continuing And Discontinued Operation
$ -80.91M$ -83.01M$ -104.92M$ -69.42M$ -30.29M$ -23.14M
Normalized Income
$ -80.91M$ -83.01M$ -102.44M$ -47.30M$ -31.24M$ -18.65M
Interest Expense
$ 4.46M$ 3.37M$ 1.71M$ 1.30M$ 990.00K$ 853.00K
$ -76.42M$ -79.64M$ -103.21M$ -68.12M$ -29.30M$ -22.29M
$ -69.06M$ -73.01M$ -99.29M$ -66.94M$ -28.32M$ -22.13M
Currency in USD

Molecular Templates Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis